|
gptkbp:instanceOf
|
contraceptive patch
|
|
gptkbp:alternativeTo
|
gptkb:NuvaRing
oral contraceptive pill
|
|
gptkbp:approvalYear
|
2001
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
G03AA13
|
|
gptkbp:brand
|
norelgestromin/ethinyl estradiol
|
|
gptkbp:contains
|
gptkb:ethinyl_estradiol
norelgestromin
|
|
gptkbp:countryOfOperation
|
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:effect
|
1 week per patch
|
|
gptkbp:form
|
musical composition
|
|
gptkbp:frequency
|
once weekly
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ortho Evra
|
|
gptkbp:legalStatus
|
Rx-only
|
|
gptkbp:manufacturer
|
gptkb:Janssen_Pharmaceuticals
|
|
gptkbp:marketedAs
|
gptkb:Evra
|
|
gptkbp:mechanismOfAction
|
inhibits ovulation
alters endometrial lining
thickens cervical mucus
|
|
gptkbp:notRecommendedFor
|
women over 35 who smoke
women with history of blood clots
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:replacedBy
|
gptkb:Xulane
|
|
gptkbp:riskFactor
|
increased risk of blood clots
|
|
gptkbp:routeOfAdministration
|
transdermal
|
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
skin irritation
|
|
gptkbp:usedFor
|
birth control
|
|
gptkbp:withdrawn
|
gptkb:Canada
gptkb:United_Kingdom
|
|
gptkbp:bfsParent
|
gptkb:EVRA
|
|
gptkbp:bfsLayer
|
7
|